Publication | Open Access

Treatment of pancreatic cancer with a combination of irinotecan (CPT-11) and gemcitabine: a multicenter phase II study by the Greek Cooperative Group for Pancreatic Cancer

Pancreatic CancerGastrointestinal OncologyGreek Cooperative GroupMedicinePharmacologyPharmacotherapyCancer TreatmentOncologyRadiation Oncology